143 related articles for article (PubMed ID: 8623418)
1. CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice.
Weber CJ; Hagler MK; Chryssochoos JT; Larsen CP; Pearson TC; Jensen P; Kapp JA; Linsley PS
Transplant Proc; 1996 Apr; 28(2):821-3. PubMed ID: 8623418
[No Abstract] [Full Text] [Related]
2. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice.
Weber CJ; Hagler MK; Chryssochoos JT; Kapp JA; Korbutt GS; Rajotte RV; Linsley PS
Cell Transplant; 1997; 6(5):505-8. PubMed ID: 9331502
[No Abstract] [Full Text] [Related]
3. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs.
Safley SA; Kapp JA; Weber CJ
Cell Transplant; 2002; 11(7):695-705. PubMed ID: 12518896
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
[No Abstract] [Full Text] [Related]
6. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
Rehman A; Tu Y; Flye MW
Transplant Proc; 1996 Apr; 28(2):660-1. PubMed ID: 8623331
[No Abstract] [Full Text] [Related]
7. Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice.
Weber C; D'Agati V; Ward L; Costanzo M; Rajotte R; Reemtsma K
Transplant Proc; 1993 Feb; 25(1 Pt 1):462-3. PubMed ID: 8438379
[No Abstract] [Full Text] [Related]
8. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
Mathieu C; Laureys J; Waer M; Bouillon R
Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
[No Abstract] [Full Text] [Related]
9. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
10. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
Rastellini C; Salam A; Kuddus R; Aitouche A; Subbotin V; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1242-3. PubMed ID: 10083554
[No Abstract] [Full Text] [Related]
11. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
[TBL] [Abstract][Full Text] [Related]
12. Local CTLA4Ig synergizes with one-dose anti-LFA-1 to achieve long-term acceptance of pancreatic islet allografts.
Chahine AA; Yu M; McKernan M; Stoeckert C; Linsley PS; Lau HT
Transplant Proc; 1994 Dec; 26(6):3296. PubMed ID: 7998139
[No Abstract] [Full Text] [Related]
13. NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets.
Weber C; Ayres-Price J; Costanzo M; Becker A; Stall A
Transplant Proc; 1994 Jun; 26(3):1116-9. PubMed ID: 8029851
[No Abstract] [Full Text] [Related]
14. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
Fernandes JR; Duvivier-Kali VF; Keegan M; Hollister-Lock J; Omer A; Su S; Bonner-Weir S; Feng S; Lee JS; Mulligan RC; Weir GC
Transpl Immunol; 2004 Nov; 13(3):191-200. PubMed ID: 15381202
[TBL] [Abstract][Full Text] [Related]
15. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
[No Abstract] [Full Text] [Related]
16. Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice.
Weber CJ; Hagler M; Konieczny B; Chryssochoos J; Rajotte R; Lakkis F; Lowry R
Transplant Proc; 1995 Dec; 27(6):3308-11. PubMed ID: 8539965
[No Abstract] [Full Text] [Related]
17. Effects of virus expressing CTLA4-IG and IL1-RA on islet xenografts.
Lu WT; Lee WC; Hsu BR; Juang JH; Fu SH; Kuo CH
Transplant Proc; 2001; 33(1-2):713-4. PubMed ID: 11267033
[No Abstract] [Full Text] [Related]
18. Effects of host genetic background and microencapsulation on survival of rat-to-mouse islet xenografts.
Weber C; Tanna A; Costanzo M; Ayres-Price J; Peterson L; Wicker L
Transplant Proc; 1994 Jun; 26(3):1186-8. PubMed ID: 8029880
[No Abstract] [Full Text] [Related]
19. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets.
Cui H; Tucker-Burden C; Cauffiel SM; Barry AK; Iwakoshi NN; Weber CJ; Safley SA
Transplantation; 2009 Jul; 88(2):160-9. PubMed ID: 19623010
[TBL] [Abstract][Full Text] [Related]
20. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
Transplant Proc; 1992 Jun; 24(3):934. PubMed ID: 1604671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
